Literature DB >> 19361607

Relation between heart rate response to adenosine and mortality in patients with end-stage renal disease.

Rajesh Venkataraman1, Fadi G Hage, Todd A Dorfman, Jaekyeong Heo, Raed A Aqel, Angelo M de Mattos, Ami E Iskandrian.   

Abstract

This study examined the relation between heart rate (HR) response to adenosine and outcome in patients with end-stage renal disease (ESRD). The usual HR increase during adenosine infusion was caused by direct sympathetic stimulation. It was hypothesized that a blunted HR response, which was probably caused by sympathetic denervation, would be associated with a worse outcome in patients with ESRD. One hundred thirty-nine patients with ESRD being evaluated for renal transplantation who underwent coronary angiography and adenosine gated single-photon emission computed tomographic myocardial perfusion imaging were followed up for all-cause mortality. Percentage of change in HR (%DeltaHR) was calculated as [(peak HR during adenosine infusion - HR at rest)/HR at rest] * 100. A control group of 54 patients (normal renal function and no diabetes) was included for comparison of HR responses. Mean age of patients was 54 +/- 9 years, 30% were women, and 68% had type-2 diabetes mellitus. %DeltaHR was 19.2 +/- 18% in patients with ESRD versus 33 +/- 25% in the control group (p <0.0001). At a mean follow-up of 3.4 +/- 1.5 years, 50 patients (36%) with ESRD died. %DeltaHR was lower in nonsurvivors than survivors (12.6 +/- 14% vs 23 +/- 19%; p = 0.0017). Patients with %DeltaHR less than the median value were more likely to have lower left ventricular ejection fraction and larger end-diastolic volume (p <0.05 for each). In a multivariate logistic regression model, %DeltaHR alone was an independent predictor of all-cause mortality (adjusted odds ratio 5.5, 95% confidence interval 2.3 to 12.9, p = 0.0001). In conclusion, patients with ESRD had a blunted HR response to adenosine, and degree of blunting was strongly associated with all-cause mortality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19361607     DOI: 10.1016/j.amjcard.2009.01.007

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Heart rate response during vasodilator stress myocardial perfusion imaging: Mechanisms and implications.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

2.  Heart rate response to regadenoson: Making the case for its value in clinical practice.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-08-27       Impact factor: 5.952

3.  Prognostic value of myocardial perfusion imaging performed pre-renal transplantation: post-transplantation follow-up and outcomes.

Authors:  Christopher W Ives; Wael A AlJaroudi; Vineeta Kumar; Ayman Farag; Dana V Rizk; Suzanne Oparil; Ami E Iskandrian; Fadi G Hage
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-07       Impact factor: 9.236

Review 4.  Cardiovascular imaging in diabetes mellitus.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-10       Impact factor: 5.952

Review 5.  Review of cardiovascular imaging in the journal of nuclear cardiology in 2016: Part 2 of 2-myocardial perfusion imaging.

Authors:  Fadi G Hage; Wael A AlJaroudi
Journal:  J Nucl Cardiol       Date:  2017-04-06       Impact factor: 5.952

6.  Prognostic value of vasodilator response using rubidium-82 positron emission tomography myocardial perfusion imaging in patients with coronary artery disease.

Authors:  Punitha Arasaratnam; Masoud Sadreddini; Yeung Yam; Vinay Kansal; Sharmila Dorbala; Marcelo F Di Carli; Rob S Beanlands; Michael E Merhige; Brent A Williams; Emir Veledar; James K Min; Li Chen; Terrence D Ruddy; Guido Germano; Daniel S Berman; Leslee J Shaw; Benjamin J W Chow
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-11-27       Impact factor: 9.236

7.  Prognostic value of heart rate response during regadenoson stress myocardial perfusion imaging in patients with end stage renal disease.

Authors:  Wael AlJaroudi; Tania Campagnoli; Ibtihaj Fughhi; Marwan Wassouf; Amjad Ali; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2015-08-22       Impact factor: 5.952

8.  The prognostic value of heart rate response during vasodilator stress myocardial perfusion imaging in patients with end-stage renal disease undergoing renal transplantation.

Authors:  Wael AlJaroudi; Chiedozie Anokwute; Ibtihaj Fughhi; Tania Campagnoli; Marwan Wassouf; Aviral Vij; Michael Kharouta; Andrew Appis; Amjad Ali; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2017-09-18       Impact factor: 5.952

9.  Impact of left ventricular dyssynchrony by phase analysis on cardiovascular outcomes in patients with end-stage renal disease.

Authors:  Wael AlJaroudi; Himanshu Aggarwal; Rajesh Venkataraman; Jaekyeong Heo; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2010-07-24       Impact factor: 5.952

Review 10.  The prognostic value of non-perfusion variables obtained during vasodilator stress myocardial perfusion imaging.

Authors:  Navkaranbir S Bajaj; Siddharth Singh; Ayman Farag; Stephanie El-Hajj; Jack Heo; Ami E Iskandrian; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2016-03-03       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.